DOI: 10.1055/s-00000069

Seminars in Liver Disease

References

Harrison SA, Marri SR, Chalasani N. , et al.
Randomised clinical study: GR-MD-02, a galectin-3 inhibitor, vs. placebo in patients having non-alcoholic steatohepatitis with advanced fibrosis.

Aliment Pharmacol Ther 2016;
44 (11-12): 1183-1198

Harrison SA, Marri SR, Chalasani N. , et al.
Randomised clinical study: GR-MD-02, a galectin-3 inhibitor, vs. placebo in patients having non-alcoholic steatohepatitis with advanced fibrosis.

Aliment Pharmacol Ther 2016;
44 (11-12): 1183-1198

Download Bibliographical Data

Search in:
Access: